Common Stock, Shares, Outstanding of CytoDyn Inc. from 31 May 2011 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CytoDyn Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 May 2011 to 30 Nov 2025.
  • CytoDyn Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Nov 2025 was 1,265,853,000, a 3.5% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

CytoDyn Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,265,853,000 +42,778,000 +3.5% 30 Nov 2025 10-Q 09 Jan 2026 2026 Q2
Q3 2025 1,256,759,000 +36,918,000 +3% 31 Aug 2025 10-Q 10 Oct 2025 2026 Q1
Q2 2025 1,249,174,000 +190,615,000 +18% 31 May 2025 10-Q 09 Jan 2026 2026 Q2
Q1 2025 1,232,305,000 +242,380,000 +24% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q3
Q4 2024 1,223,075,000 +251,789,000 +26% 30 Nov 2024 10-Q 14 Jan 2025 2025 Q2
Q3 2024 1,219,841,000 +288,884,000 +31% 31 Aug 2024 10-Q 15 Oct 2024 2025 Q1
Q2 2024 1,058,559,000 +139,949,000 +15% 31 May 2024 10-K 25 Jul 2025 2025 FY
Q1 2024 989,925,000 +153,337,000 +18% 29 Feb 2024 10-Q 15 Apr 2024 2024 Q3
Q4 2023 971,286,000 +146,450,000 +18% 30 Nov 2023 10-Q 16 Jan 2024 2024 Q2
Q3 2023 930,957,000 +118,702,000 +15% 31 Aug 2023 10-Q 23 Oct 2023 2024 Q1
Q2 2023 918,610,000 +199,025,000 +28% 31 May 2023 10-K 15 Aug 2024 2024 FY
Q1 2023 836,588,000 +123,301,000 +17% 28 Feb 2023 10-Q 10 Apr 2023 2023 Q3
Q4 2022 824,836,000 +139,418,000 +20% 30 Nov 2022 10-Q 09 Jan 2023 2023 Q2
Q3 2022 812,255,000 +168,578,000 +26% 31 Aug 2022 10-Q/A 13 Oct 2022 2023 Q1
Q2 2022 719,585,000 +93,905,000 +15% 31 May 2022 10-K 14 Sep 2023 2023 FY
Q1 2022 713,287,000 +104,309,000 +17% 28 Feb 2022 10-Q 11 Apr 2022 2021 Q3
Q4 2021 685,418,000 +95,581,000 +16% 30 Nov 2021 10-Q 10 Jan 2022 2021 Q2
Q3 2021 643,677,000 +73,794,000 +13% 31 Aug 2021 10-Q 12 Oct 2021 2021 Q1
Q2 2021 625,680,000 +106,704,000 +21% 31 May 2021 10-K 15 Aug 2022 2022 FY
Q1 2021 608,978,000 +138,171,902 +29% 28 Feb 2021 10-Q 14 Apr 2021 2020 Q3
Q4 2020 589,837,000 +260,282,237 +79% 30 Nov 2020 10-Q 08 Jan 2021 2020 Q2
Q3 2020 569,883,000 +186,457,644 +49% 31 Aug 2020 10-Q 09 Oct 2020 2020 Q1
Q2 2020 518,976,000 +189,580,248 +58% 31 May 2020 10-K 30 Jul 2021 2021 FY
Q1 2020 470,806,098 +166,286,028 +55% 29 Feb 2020 10-Q 09 Apr 2020 2020 Q3
Q4 2019 329,554,763 +38,904,814 +13% 30 Nov 2019 10-Q 09 Jan 2020 2020 Q2
Q3 2019 383,425,356 +149,703,977 +64% 31 Aug 2019 10-Q 08 Oct 2019 2020 Q1
Q2 2019 329,395,752 +112,672,973 +52% 31 May 2019 10-K 14 Aug 2020 2020 FY
Q1 2019 304,520,070 +95,616,070 +46% 28 Feb 2019 10-Q 09 Apr 2019 2019 Q3
Q4 2018 290,649,949 +125,514,795 +76% 30 Nov 2018 10-Q 09 Jan 2019 2019 Q2
Q3 2018 233,721,379 +80,958,136 +53% 31 Aug 2018 10-Q 09 Oct 2018 2019 Q1
Q2 2018 216,722,779 +67,254,535 +45% 31 May 2018 10-K 14 Aug 2019 2019 FY
Q1 2018 208,904,000 +59,435,756 +40% 28 Feb 2018 10-Q 09 Apr 2018 2018 Q3
Q4 2017 165,135,154 +26,913,172 +19% 30 Nov 2017 10-Q 08 Jan 2018 2018 Q2
Q3 2017 152,763,243 +29,427,609 +24% 31 Aug 2017 10-Q 10 Oct 2017 2018 Q1
Q2 2017 149,468,244 +26,132,610 +21% 31 May 2017 10-K 27 Jul 2018 2018 FY
Q1 2017 149,468,244 +85,823,896 +135% 28 Feb 2017 10-Q 13 Apr 2017 2017 Q3
Q4 2016 138,221,982 +74,577,634 +117% 30 Nov 2016 10-Q 13 Jan 2017 2017 Q2
Q3 2016 123,335,634 +59,691,286 +94% 31 Aug 2016 10-Q 12 Oct 2016 2017 Q1
Q2 2016 123,335,634 +59,691,286 +94% 31 May 2016 10-K 20 Jul 2017 2017 FY
Q1 2016 63,644,348 +4,385,232 +7.4% 29 Feb 2016 10-Q 13 Apr 2016 2016 Q3
Q4 2015 63,644,348 +4,910,873 +8.4% 30 Nov 2015 10-Q 11 Jan 2016 2016 Q2
Q3 2015 63,644,348 +7,891,845 +14% 31 Aug 2015 10-Q 09 Oct 2015 2016 Q1
Q2 2015 63,644,348 +7,891,037 +14% 31 May 2015 10-K 19 Jul 2016 2016 FY
Q1 2015 59,259,116 +3,690,735 +6.6% 28 Feb 2015 10-Q 10 Apr 2015 2015 Q3
Q4 2014 58,733,475 +3,397,454 +6.1% 30 Nov 2014 10-Q 12 Jan 2015 2015 Q2
Q3 2014 55,752,503 +23,711,568 +74% 31 Aug 2014 10-Q 10 Oct 2014 2014 Q1
Q2 2014 55,753,311 +24,845,019 +80% 31 May 2014 10-K 10 Jul 2015 2015 FY
Q1 2014 55,568,381 +24,822,710 +81% 28 Feb 2014 10-Q 11 Apr 2014 2014 Q3
Q4 2013 55,336,021 +25,429,650 +85% 30 Nov 2013 10-Q 13 Jan 2014 2014 Q2
Q3 2013 32,040,935 +2,142,374 +7.2% 31 Aug 2013 10-Q 15 Oct 2013 2014 Q1
Q2 2013 30,908,292 +2,271,762 +7.9% 31 May 2013 10-K 10 Jul 2014 2014 FY
Q1 2013 30,745,671 +2,637,715 +9.4% 28 Feb 2013 10-Q 12 Apr 2013 2013 Q3
Q4 2012 29,906,371 +7,615,389 +34% 30 Nov 2012 10-Q 14 Jan 2013 2013 Q2
Q3 2012 29,898,561 +7,607,579 +34% 31 Aug 2012 10-Q/A 08 Nov 2012 2013 Q1
Q2 2012 28,636,530 +6,345,548 +28% 31 May 2012 10-K 29 Aug 2013 2013 FY
Q1 2012 28,107,956 29 Feb 2012 10-Q 16 Apr 2012 2012 Q3
Q4 2011 22,290,982 30 Nov 2011 10-Q 17 Jan 2012 2012 Q2
Q3 2011 22,290,982 31 Aug 2011 10-Q/A 30 Nov 2011 2012 Q1
Q2 2011 22,290,982 31 May 2011 10-K 22 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.